Iboga is a shrub native to West Central Africa — botanically Tabernanthe iboga — whose root bark contains a dozen psychoactive alkaloids. The best known of them is ibogaine, the compound used in modern addiction medicine.
That distinction is the source of most confusion in this field: iboga is the plant, ibogaine is the single purified molecule extracted from it. This guide covers both — where the plant comes from, the Bwiti tradition it belongs to, how it reached Western medicine, and what is actually used in clinics today.
The plant itself
Tabernanthe iboga is an evergreen shrub that grows in the understory of the rainforests of Gabon, Cameroon and neighbouring parts of West Central Africa. It produces small yellowish-pink fruit, but the part that matters pharmacologically is the root bark, where the alkaloid content is concentrated.
Ibogaine is only one of roughly a dozen alkaloids in that bark, alongside ibogamine, tabernanthine and others. This is why the plant and the isolated compound do not behave identically — a point that becomes important later.
A second plant matters commercially: Voacanga africana, a tree from the same botanical family. It is more abundant and easier to harvest at scale, and it has become the main source of the ibogaine used in clinics worldwide.
Iboga in the Bwiti tradition
Iboga is not a folk remedy in its own culture — it is a sacrament. In Gabon it is central to Bwiti, a religion in which the plant is regarded as sacred and is taken in structured ceremony rather than casually.
Its best-known use is initiation. Around the age of seventeen, initiates take iboga in a ceremony that typically lasts about three days. In Bwiti understanding, the plant transforms an adolescent into an adult: after the ceremony, the initiate takes on the roles and responsibilities that adulthood carries in that community.
This context deserves respect for a practical reason as well as a cultural one. The traditional ceremony and a hospital ibogaine treatment share a plant and almost nothing else — different preparation, different dose, different purpose, different safeguards. Neither is a substitute for the other.
How iboga reached Western medicine
The turning point came in 1962, and not in a laboratory. Howard Lotsof, a young American dependent on heroin, took ibogaine expecting an intense psychoactive experience. What he described afterwards was something else entirely: roughly a day later he was neither in withdrawal nor experiencing cravings.
That single observation reframed the plant. Interest shifted from its ceremonial and psychoactive properties to a specific clinical question — whether one dose could interrupt dependence rather than manage it — and that question is what the field has been pursuing ever since.
Iboga vs ibogaine — what's the difference?
In everyday use the words are swapped freely, but clinically they mean different things.
Iboga refers to the plant and its traditional preparations — root bark, either chewed or prepared as a powder — containing the full spectrum of alkaloids in whatever proportions that particular plant happened to produce.
Ibogaine is the single alkaloid, isolated and purified. In clinics it is usually ibogaine hydrochloride (HCl), typically above 90% purity.
Total alkaloid extract (TA) sits between the two: a purified extract that retains ibogaine plus the other alkaloids.
The reason most medical programs use purified ibogaine is dosing precision. Treatment is calculated by body weight, so the clinician has to know exactly how much active compound is being given — something that is simply not possible with raw plant material of unknown alkaloid content. When the main safety risk is cardiac and dose-related, that uncertainty is not a small matter.
Iboga vs ibogaine — full comparison →
What iboga is used for today
Outside its traditional setting, iboga-derived ibogaine has one principal medical application: interrupting substance dependence.
The clearest effect is on opioid withdrawal, which typically stops within the first hours of a supervised session. It is also used for cocaine and crack dependence — in Brazil, where ibogaine has been used clinically since the 1990s, stimulant patients outnumber opioid patients — and for alcohol dependence. Research into trauma, PTSD and treatment-resistant depression is ongoing but earlier-stage.
What ibogaine does not do is complete the job by itself. In the hospital-based protocol run by Dr. Bruno Rasmussen in Brazil, ibogaine is treated as a psychotherapy facilitator: the session removes withdrawal and craving, and structured psychotherapy — roughly four sessions before treatment and four after — does the work of recovery. Patients who decline the psychotherapy are not accepted for treatment at all.
What is ibogaine → · Ibogaine for opioid addiction →
What about iboga microdosing?
Microdosing iboga — taking small sub-psychoactive amounts of root bark or ibogaine, often for mood, focus or energy — is a common search topic and is sold widely online. It deserves a direct answer rather than a marketing one.
There is no meaningful clinical evidence base for iboga microdosing. It has not been studied in the way the full-dose addiction protocol has, and the outcomes people report come from self-experimentation rather than trials.
More importantly, the main safety consideration does not disappear at lower doses. Ibogaine affects cardiac conduction, and unsupervised use — without an ECG, without knowing the alkaloid content of the material, and without knowing how it interacts with your medication — carries risk that no amount of dose reduction removes on its own.
Our position is straightforward: we do not advise self-administered iboga in any form, at any dose.
Safety and legal status
Iboga and ibogaine are psychoactive substances with real cardiac risk. In medical settings that risk is managed by screening — an ECG, blood tests, a clinical and psychological review — and by continuous monitoring during the session. In responsible programmes, a significant share of people who apply are found unsuitable and are not treated.
Legally, the picture varies by country. Ibogaine is controlled in the United States and restricted across much of Europe. In Brazil it is not scheduled, but it is not a registered medicine either — a legal grey area; clinics import it for each named patient, and in São Paulo state treatment is recommended to take place in a hospital. In Gabon, iboga holds protected cultural status.
Is ibogaine safe? → · Ibogaine legality by country →
Sustainability
Growing international interest in iboga has raised real concerns about the pressure on wild Tabernanthe iboga populations in Gabon, where the plant is slow-growing and culturally significant. This is one practical reason the clinical supply chain has largely moved to Voacanga africana, which is more abundant, and to semi-synthetic production.
It is a reasonable question to ask any provider: where does their ibogaine come from, and at what purity?
Considering treatment?
If you have arrived here researching iboga for yourself or someone close to you, the practical question is usually not botanical — it is whether supervised ibogaine treatment is a realistic option, and where it can be done safely.
Rehab Global does not own clinics, and if treatment is not appropriate in your case, we will say so.
Free and confidential. Our team reviews your case and replies within 24 hours.